BMY
Bristol-Myers Squibb Company
October 20, 2026 · market open
- Rarity
- 1.24
- Peak move
- +4.89%
- Float cap
- $119.5B
Still running — rarity and peak move can only rise from here.
Bristol-Myers Squibb Company is a biopharmaceutical company that discovers, develops, licenses, manufactures, markets, distributes, and sells innovative medicines for serious diseases. Its therapies target oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. Products are sold worldwide, primarily to wholesalers, distributors, specialty pharmacies, and, to a lesser extent, retailers, hospitals, clinics, government agencies, and patients.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNothing found.We searched SEC filings, the newswires and the open web across the three days around this move and found no public information that explains it.